The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients

The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients

Abstract Background Pancreatic cancer (PC) patients have multiple risk factors for sarcopenia and loss of skeletal muscle mass (LSMM), which may cause greater treatment toxicities, reduced response to cancer therapy, prolonged hospitalization, impaired quality of life, and worse prognosis. Methods T...

Full description

Bibliographic Details
Main Authors: Debora Basile, Annamaria Parnofiello, Maria Grazia Vitale, Francesco Cortiula, Lorenzo Gerratana, Valentina Fanotto, Camilla Lisanti, Giacomo Pelizzari, Elena Ongaro, Michele Bartoletti, Silvio Ken Garattini, Victoria Josephine Andreotti, Anna Bacco, Donatella Iacono, Marta Bonotto, Mariaelena Casagrande, Paola Ermacora, Fabio Puglisi, Nicoletta Pella, Gianpiero Fasola, Giuseppe Aprile, Giovanni G. Cardellino
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Sarcopenia
Pancreatic cancer
Muscle loss
Muscle depletion
Online Access:https://doi.org/10.1002/jcsm.12368

Internet

https://doi.org/10.1002/jcsm.12368

Similar Items